Former Chief Financial Officer · AGIOS PHARMACEUTICALS, INC. (AGIO)

Andrew Hirsch

A named executive officer of AGIOS PHARMACEUTICALS in every fiscal year CompBrief holds from FY2016 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$2,886,122

Salary $361,234Stock awards $618,120

FY2019: $4,248,831

4th of 5 named executive officers at Agios Pharmaceuticals by FY2020 total.

5 named officers on file for AGIOS PHARMACEUTICALS, FY2020

Andrew Hirsch’s pay file — $29

  • 5 fiscal years of pay, line by line
  • 8 equity grants, each cited to its filing
  • AGIO’s disclosed peer group of 14 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how AGIOS PHARMACEUTICALS’s whole pay program stands against its peers

  • AGIOS PHARMACEUTICALS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on AGIO→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 8, 2021 (DEF 14A).

Free

Get Andrew Hirsch’s full pay file as a PDF — free

More than this page: up to 10 years of Andrew’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Andrew Hirsch compensation by year

AGIOS PHARMACEUTICALS Summary Compensation Table · all 5 fiscal years held
In US dollars, as AGIOS PHARMACEUTICALS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019FY2020
Salary$126,667$453,201$471,329$500,476$361,234
Bonus$0$0$0$0$0
Stock awards$747,450$0$641,025$1,923,145$618,120
Option awards$4,186,746$1,639,353$1,746,517$1,609,989$1,508,875
Non-equity incentive$176,000$217,537$265,123$202,693$0
Pension and deferred compensation$0$0$0$0$0
All other$698$9,964$12,864$12,528$397,893
Total$5,237,561$2,320,055$3,136,858$4,248,831$2,886,122

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: AGIOS PHARMACEUTICALS, INC. DEF 14A filed April 8, 2021, accession 0001193125-21-110205, and prior-year filings. Open the filing on EDGAR.

How this page was built: the AGIOS PHARMACEUTICALS, INC. filed document, accession 0001193125-21-110205. Every figure is read from that document and cited to the page and table it appears in. Filed April 8, 2021.

$5.2M
$2.3M
$3.1M
$4.2M
$2.9M
FY16
FY17
FY18
FY19
FY20
SalaryNon-equity incentiveStock awardsOption awardsAll other

AGIOS PHARMACEUTICALS’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Jacqualyn FouseFormer Chief Executive Officer$7,611,975
Bruce CarFormer Chief Scientific Officer$3,228,043
Christopher BowdenFormer Chief Medical Officer$2,894,546
Andrew Hirsch · this pageFormer Chief Financial Officer$2,886,122
Jonathan BillerChief Financial Officer, Head of Legal and Corporate Affairs$769,328

The full AGIOS PHARMACEUTICALS compensation record

free company brief

This page is one person within AGIOS PHARMACEUTICALS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are AGIOS PHARMACEUTICALS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Andrew Hirsch's compensation dossier · One-time report. No refunds.